Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancer

BACKGROUND: Bevacizumab has become standard of care as first-line treatment of metastatic colorectal cancer (mCRC), after proving increased response rates and improvement in survival outcomes. Hypertension (HTN) is a common complication of the treatment with bevacizumab and, owing to its close relat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:ESMO Open
Hlavní autoři: Dionísio de Sousa, Isabel José, Ferreira, Joana, Rodrigues, Joana, Bonito, Nuno, Jacinto, Paula, Marques, Mariela, Ribeiro, João, Pais, Ana, Gervásio, Helena
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2016
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070256/
https://ncbi.nlm.nih.gov/pubmed/27843607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000045
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky